Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial
暂无分享,去创建一个
T. Fujita | F. Gejyo | H. Origasa | T. Kiriyama | A. Koyama | Kiyonobu Okada | M. Isono | H. Kurumatani | Hiroyuki Kanoh | S. Yamada